Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.540
-0.210 (-12.00%)
At close: Nov 20, 2025, 4:00 PM EST
1.490
-0.050 (-3.25%)
Pre-market: Nov 21, 2025, 9:04 AM EST
RANI Stock Forecast
Stock Price Forecast
The 6 analysts that cover RANI stock have a consensus rating of "Strong Buy" and an average price target of $8.67, which forecasts a 462.99% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $11.
Price Target: $8.67 (+462.99%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 21, 2025.
Analyst Ratings
The average analyst rating for RANI stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +614.29% | Oct 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +549.35% | Oct 20, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $4 | Buy | Maintains | $14 → $4 | +159.74% | May 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +484.42% | Apr 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +484.42% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
194.48K
from 1.03M
Decreased by -81.08%
Revenue Next Year
n/a
from 194.48K
EPS This Year
-0.40
from -1.05
EPS Next Year
-0.27
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 210,000 | n/a | |||
| Avg | 194,483 | n/a | |||
| Low | 168,560 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -79.6% | - | |||
| Avg | -81.1% | - | |||
| Low | -83.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.21 | -0.18 | |||
| Avg | -0.40 | -0.27 | |||
| Low | -0.58 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.